GVR Report cover Orthokeratology Lens Market (2026 - 2033)Report

Orthokeratology Lens Market (2026 - 2033)

Size, Share & Trends Analysis Report By Product, By Distribution Channel (Hospitals, Optometry Clinics), By Indication (myopia, Presbyopia, Hypermetropia, Astigmatism), By Region, And Segment Forecasts

Market Size, 2025

$786.1M

Market Estimate, 2026

$837.7M

Market Forecast, 2033

$1,256.5M

CAGR, 2026–2033

6.7%

Orthokeratology Lens Market Summary

The global orthokeratology lens market size was valued at USD 786.1 million in 2025 and is projected to grow from USD 837.7 million in 2026 to USD 1,256.5 million by 2033, at a CAGR of 6.0% from 2026 to 2033. The market in North America dominated with a revenue share of 37.1% in 2025. The global market for orthokeratology lens is rapidly growing, fueled by rising awareness of myopia management and increasing refractive errors. The introduction of advanced overnight ortho-K lenses, along with more FDA approvals, is driving demand. 

Orthokeratology lens market overview: Grand View Research estimates the global market size at USD 786.1 million in 2025, projected to grow from USD 837.7 million in 2026 to USD 1,256.5 million by 2033 at a 6.0% CAGR, with regional growth momentum.Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, icon Download Free Sample Report

Key Market Trends & Insights

  • By product type: Overnight ortho-k lenses segment held the largest market share of 94.5% in 2025.
  • By indication: Myopia segment held the largest market share of 41.1% in 2025.
  • By distribution channel: Ophthalmology clinics segment held the largest market share of 30.1% in 2025.

Regional Highlights

  • Largest regional market: North America (37.1% revenue share, 2025)
  • Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
  • By country: U.S. held the largest market share in 2025

Market Size & Forecast

  • Market size in 2025: USD 786.1 Million
  • Estimated market size in 2026: USD 837.7 Million
  • Projected market size by 2033: USD 1,256.5 Million
  • CAGR (2026-2033): 6.0%

Three ways to get this report

Buy it, customize it, or ask a question.

Ask an Analyst

Analyst response in 1 business day

  • AccessReport author, directly
  • Reply timeWithin 1 working day
  • No sales callDirect answer only
  • FormatEmail reply
  • CostFree, no cost

Customize the Report

20% free customization

  • IncludeCountries, segments, points
  • TailorTo your product definition
  • ExtendDeeper competitor detail
  • OrA fully bespoke study
  • Turnaround5–10 working days
ISO 9001 & 27001 certified ESOMAR member Not sure which fits? Call +1-415-349-0058

Orthokeratology lenses, also known as ortho-K lenses, are specialized gas-permeable contact lenses designed to reshape the cornea overnight, allowing individuals to enjoy clear vision throughout the day without the need for glasses or contact lenses. One of the key factors propelling the growth of the ortho-K lens market is the alarming rise in myopia cases worldwide. According to the World Health Organization (WHO), approximately 2.7 billion people globally are affected by myopia, with projections suggesting that this number could soar to 5 billion by 2050. This increasing prevalence, particularly among children and young adults, has made ortho-K lenses an attractive solution for parents seeking effective ways to manage their children's vision. A study published in the journal Ophthalmology indicated that ortho-K can reduce the progression of myopia in children by up to 50%, further solidifying its role in myopia control.

Orthokeratology lens market size and growth forecast (2023-2033)

To learn more about this report, icon Download Free Sample Report

Advancements in lens technology are also contributing significantly to the growth of the market. Recent innovations in lens design and materials have greatly enhanced both comfort and effectiveness. For instance, the development of overnight ortho-K lenses utilizing advanced gas-permeable materials allows for better oxygen transmission, significantly reducing the risk of complications and improving patient satisfaction. Moreover, the integration of digital technology, such as wavefront analysis, enables eye care professionals to create highly customized lenses that enhance the overall efficacy of treatment.

The increase in screen time due to digital devices also plays a crucial role in market growth. A study by the Vision Council reported that over 60% of adults experience symptoms of digital eye strain, leading to heightened awareness regarding eye care and the importance of effective vision correction methods. This trend is driving more individuals to consider ortho-K lenses as a viable solution.

In addition, the young generation prefers the trendy look and has different eyewear based on the occasion. Consumers demand newer designs and technologies, which forces companies to consistently focus on R&D to develop innovative products. An increasing number of awareness programs in developing economies for eye disease diagnosis is estimated to boost the demand for orthokeratology lenses during the forecast period. Vision correction in kids has resulted in better academic performance, which, in turn, results in higher demand for overnight ortho-K-lens.

Orthokeratology lenses are safe, specifically among children, owing to their easy usage. The capability to improve patients’ visualization and quality of life with the use of orthokeratology is one of the most stimulating developments in the ophthalmic industry. With advancements in diagnostic technology and lens materials, orthokeratology is a possible alternative to invasive surgery. In addition, companies working in the market are expanding their output product capacities including orthokeratology lenses to resolve various corneal disorders including myopia and astigmatism.

Market Dynamics

The orthokeratology lens market is gaining significant traction as ophthalmology clinics, optometry centers, vision care practices, specialty eye hospitals, and pediatric eye care providers increasingly adopt orthokeratology (Ortho-K) lenses for non-surgical vision correction and myopia management. These lenses encompass a broad range of customized rigid gas permeable (RGP) lenses designed to temporarily reshape the cornea during overnight wear, enabling clear daytime vision without the need for spectacles or contact lenses.

These advanced lens technologies enable patients to achieve effective correction of myopia, low-to-moderate astigmatism, and certain refractive errors while supporting long-term vision management. Orthokeratology lenses play a critical role in addressing the growing burden of myopia, particularly among children and adolescents, by providing a non-invasive approach to slowing myopia progression. Increasing emphasis on preventive eye care, pediatric vision management, and growing awareness of myopia-related complications is driving the adoption of orthokeratology lenses across both developed and emerging vision care markets.

The orthokeratology lens market is expanding rapidly due to the increasing prevalence of myopia worldwide, particularly among children and young adults. Factors such as increased screen time, reduced outdoor activities, urbanization, intensive educational demands, and changing lifestyles have contributed to a significant rise in myopia incidence globally. As concerns regarding high myopia and associated risks such as retinal detachment, glaucoma, cataracts, and myopic macular degeneration continue to grow, demand for effective myopia management solutions is increasing substantially.

Additionally, growing clinical evidence supporting the effectiveness of orthokeratology lenses in slowing axial eye growth and myopia progression is encouraging adoption among eye care professionals and parents. Patients increasingly prefer non-surgical, reversible vision correction options that provide daytime freedom from glasses and contact lenses. As awareness of pediatric myopia management continues to expand, demand for orthokeratology lenses is expected to grow significantly.

Despite strong growth potential, the orthokeratology lens market faces challenges associated with relatively high treatment costs and the need for specialized fitting expertise. Orthokeratology treatment requires customized lens designs, detailed corneal topography assessments, ongoing follow-up visits, and professional monitoring, which can increase overall treatment expenses compared with conventional vision correction methods.

Additionally, successful orthokeratology outcomes depend heavily on practitioner expertise, patient compliance, and proper lens hygiene practices. Limited availability of trained orthokeratology specialists in certain regions can restrict patient access to treatment. Furthermore, concerns regarding lens discomfort, risk of corneal infections associated with improper lens care, and limited reimbursement coverage may reduce adoption among some patient populations. These factors can slow market penetration and create barriers to widespread adoption despite growing interest in non-surgical myopia control and vision correction solutions.

 

Market Concentration & Characteristics

The market is characterized by moderate concentration, with a mix of established players and emerging companies. Major manufacturers dominate with advanced technologies and extensive distribution networks, driving innovation and market share. The industry focuses on research and development to enhance lens comfort and efficacy, catering to the growing demand for myopia management. Additionally, increased awareness and adoption of ortho-K lenses among eye care professionals and consumers are fueling competition, leading to a wider variety of products and solutions tailored to different patient needs, particularly among children and young adults.

The orthokeratology lens industry exhibits high innovation, driven by technological advancements and a growing understanding of retinal diseases. For instance, in October 2022, advancements in smart medicine were highlighted as technology transforms eye care. Tailor-made orthokeratology lenses, designed using digital technology that analyzes nearly 10,000 data points, offer personalized solutions for refractive errors. This innovation enhances comfort and effectiveness, particularly benefiting children, while improving surgical precision through real-time imaging technology, ensuring safer procedures.

Orthokeratology Lens Industry Dynamics

To learn more about this report, icon Download Free Sample Report

Regulations significantly impact the market by ensuring safety, efficacy, and quality standards for products. Regulatory bodies, such as the FDA and European Medicines Agency, mandate rigorous testing and approval processes, which can influence market entry and innovation. Compliance with these regulations fosters consumer confidence and promotes market growth. Additionally, regulations surrounding marketing and distribution ensure that information about the lenses is accurate and transparent, helping to educate both healthcare providers and patients. As the market evolves, regulatory updates will play a crucial role in shaping product development and ensuring that advancements meet health and safety standards.

Strategic partnerships enhance innovation and allow firms to combine resources for research and development. For instance, the acquisition of Visionary Optics by Euclid Vision Corp. in April 2022 exemplifies this trend, enabling the integration of specialty scleral lens technology with advanced orthokeratology solutions. Such M&A activities not only strengthen competitive positioning but also foster collaboration among industry leaders, driving advancements in myopia management and tailored vision correction solutions to meet rising global demand.

In the market, several product substitutes exist that cater to similar vision correction needs. Traditional soft contact lenses and daily disposable lenses offer alternatives for individuals seeking comfort and convenience, while glasses remain a common choice for those preferring non-invasive options. Additionally, refractive surgical procedures, such as LASIK, provide a permanent solution for myopia and other refractive errors. However, unlike ortho-K lenses, these substitutes may not offer the same reversible effects or be suitable for younger patients. The diversity of options emphasizes the importance of tailored solutions for varying patient preferences and visual requirements.

The market is witnessing significant regional expansion, highlighted by Menicon Co., Ltd.'s announcement of launching the "Menicon Z Night" lens in China in May 2023. This strategic move aims to address the growing demand for myopia management solutions in the region, where the prevalence of refractive errors is increasing. By introducing advanced orthokeratology lenses, Menicon seeks to capture market share in China, furthering its global presence. This expansion reflects the industry's focus on innovative products tailored to specific regional needs, ultimately enhancing vision correction options for consumers worldwide.

Analyst Perspective

The increasing prevalence of myopia worldwide, awareness about the management of childhood myopia, and growing preference for non-surgical vision correction are contributing to the growth of the orthokeratology lens market. Apprehension about progressive myopia and its complications, such as retinal detachment, glaucoma, and myopic macular degeneration, is driving increased use of orthokeratology lenses. New innovations such as Corneal topography, custom lens design, digital eye-fitting solutions, and high-oxygen-permeable lens materials enhance treatment effectiveness and safety, as well as patient comfort. Increasing parental education on eye health, the rising trend in preventive vision care, and the growing availability of specialized eye care practitioners are expected to drive the expansion of this market.

Product Insights

Based on product type, the overnight ortho-K lenses segment led the market with the largest revenue share of 94.5% in 2025. This growth is driven by the high adoption rates and effectiveness of overnight ortho-K lenses. These lenses significantly alleviate discomfort often associated with conventional contact lenses, making them an attractive option for individuals who prefer not to wear glasses or contacts during the day, especially during sports. Their convenience particularly appeals to children and young adults, providing an effective solution for myopia management. As myopia prevalence rises and awareness of non-surgical alternatives increases, these lenses gain popularity. Additionally, improvements in lens materials and design enhance comfort and effectiveness, fostering continued growth in this segment as more consumers seek innovative vision correction options.

The daytime ortho-K lenses segment in the orthokeratology lens market is projected to experience the fastest compound annual growth rate (CAGR) over the forecast period. Daytime ortho-K lenses, typically worn at night, can cause discomfort and symptoms like dry eye when worn during the day, potentially hindering market growth. However, they attract a wide consumer base, especially children and young adults seeking non-surgical myopia solutions. Increased awareness of myopia’s long-term effects and advancements in lens technology enhance comfort and visual clarity, driving demand. As more eye care professionals recommend these lenses, this segment is likely to maintain a leading position in market revenues.

Indication Insights

Based on indication, the myopia segment led the market with the largest revenue share of 41.1% in 2025. The rising prevalence of myopia is expected to drive growth in the orthokeratology lenses market during the study period. As reported in the journal Investigative Ophthalmology and Visual Science, around 1.9 billion people, or about 27% of the global population, are affected by myopia. The International Myopia Institute indicates that myopia is on the rise globally, with recent estimates suggesting that 30% of the population is currently myopic, potentially increasing to nearly 50%-about 5 billion people-by 2050. This condition poses significant risks of ocular complications and high healthcare costs, making it a leading cause of permanent blindness worldwide during the forecast period.

The astigmatism segment is expected to grow at a significant CAGR during the forecast period.. The rising prevalence of astigmatism is expected to significantly increase the demand for orthokeratology lenses. According to the American Optometric Association, many individuals with astigmatism prefer corrective eyeglasses over surgery for vision improvement. Currently, about one in three people in the U.S. experiences astigmatism, a figure anticipated to grow. A recent systematic review published by NCBI in February 2023 identified astigmatism as the most common refractive error, with an estimated prevalence of 40% among adults across various World Health Organization regions, including Africa, the Americas, Southeast Asia, Europe, the Eastern Mediterranean, and the West Pacific.

Distribution Channel Insights

Based on distribution channel, the ophthalmology clinics segment led the market with the largest revenue share of 30.1% in 2025. This growth can be attributed to the increasing number of specialized clinics offering advanced myopia management solutions. These clinics provide comprehensive eye care, including personalized consultations and fitting of orthokeratology lenses, enhancing patient experiences. Additionally, the rising awareness of myopia and its associated risks has led more individuals to seek professional care. With the continued emphasis on non-surgical vision correction options and innovative treatment strategies, ophthalmology clinics are well-positioned to drive further market expansion in the orthokeratology lens sector.

Orthokeratology Lens Market Share

To learn more about this report, icon Download Free Sample Report

The optometry clinics segment of the market is expected to experience a notable increase in compound annual growth rate (CAGR) over the forecast period. This growth is driven by the rising demand for personalized eye care services, as more patients seek effective myopia management solutions. Optometry clinics play a crucial role in educating patients about the benefits of orthokeratology lenses, facilitating their adoption. Additionally, advancements in lens technology and fitting techniques enhance patient outcomes, further encouraging visits to these clinics. As awareness of vision health continues to grow, optometry clinics are expected to become key players in the market.

Regional Insights

North America dominated the orthokeratology lens market with the largest revenue share of 37.1% in 2025. The strong need for quality assurance measures for ophthalmic devices arises from the well-established healthcare infrastructure. Moreover, ongoing technological advancements, increasing awareness among end users regarding eye health, and strict regulatory standards are anticipated to drive market expansion in the future.

Orthokeratology Lens Market Trends, by Region, 2026 - 2033

To learn more about this report, icon Download Free Sample Report

U.S. Orthokeratology Lens Market Trends

The orthokeratology lens market in the U.S. held the largest share in the North America region in 2025. High awareness of retinal disorders and an established healthcare infrastructure facilitate the adoption of advanced diagnostic technologies. A recent paper published in Optometry & Vision Science highlights key trends and insights regarding the current state of orthokeratology in the U.S. The findings from the Fitting of Orthokeratology in the United States (FOKUS) survey, conducted with over 500 eye care professionals (ECPs), reveal that 56% of those actively fitting ortho-k lenses expect market growth in the coming year. Additionally, 46% of ECPs not currently fitting these lenses plan to begin prescribing them within the next two years.

Europe Orthokeratology Lens Market Trends

The European orthokeratology lens market is experiencing growth, driven by rising awareness of myopia management and the increasing prevalence of refractive errors. Innovative lens technologies and materials are enhancing comfort and effectiveness, attracting both consumers and eye care professionals. Additionally, the expansion of specialized clinics offering orthokeratology services is contributing to market development. Growing interest in non-surgical vision correction options among children and young adults’ further fuels demand.

UK orthokeratology lens market is experiencing notable growth, driven by increasing screen time among the population. According to data from Independent UK published in June 2024, Brits spend an average of 1 hour and 52 minutes daily on social media. This prolonged exposure to screens raises concerns about eye strain and exacerbates existing vision issues. As a result, there is a growing demand for effective diagnostic tools like orthokeratology lens to assess and address these vision-related problems.

The orthokeratology lens market in France is expanding, driven by a rising awareness of retinal disorders and the aging population. Increasing incidence of conditions like diabetic retinopathy and macular degeneration is fueling demand for advanced diagnostic tools. Enhanced research initiatives and improved healthcare infrastructure further support market growth in the country. According to World Bank data, France’s healthcare expenditure was around 12.31% of its GDP in 2021.

The orthokeratology lens market in Germany is experiencing robust growth, primarily driven by increasing awareness of retinal health and a significant rise in eye disorders. Notably, Staar Surgical reports that the EuroEyes clinic group performed the highest number of ICL surgeries in Germany in 2021. The aging population, coupled with a high prevalence of conditions such as diabetic retinopathy and macular degeneration, intensifies the demand for precise diagnostic tools. Germany's well-established healthcare system, supported by advanced research and technological innovations, facilitates the adoption of orthokeratology lens devices in clinical settings.

Asia Pacific Orthokeratology Lens Market Trends

The Asia Pacific orthokeratology lens market is experiencing robust growth, primarily driven by the rising prevalence of myopia, particularly among children and adolescents. According to the World Health Organization, myopia affects approximately 50% of the population in some Asian countries, such as Singapore and Taiwan. This has spurred demand for non-surgical vision correction solutions like orthokeratology lenses. Additionally, advancements in lens technology, such as the introduction of customizable lenses, are enhancing comfort and effectiveness. The growth of specialized eye care clinics and increased awareness among parents further contribute to the market expansion, making it a dynamic sector within the ophthalmic industry.

The orthokeratology lens market in Japan is set for significant growth, primarily driven by the country's aging population. As of 2023, approximately 30% of the population is aged 65 and older, making them more susceptible to eye disorders. This demographic shift is anticipated to boost demand for orthokeratology lens in the coming years.

The China orthokeratology lens market is expected to grow, driven by technological advancements and heightened research and development in the field of orthokeratology. The China National Medical Products Administration (NMPA) is responsible for overseeing medical devices, including orthokeratology lens, to guarantee their safety, effectiveness, and adherence to regulatory requirements.

The orthokeratology lens market in India is poised for substantial growth, driven by rising contact lens usage and growing awareness of eye health. With an annual growth rate of 15% to 20%, this trend reflects shifting preferences among Indians toward contact lenses for vision correction. Factors like increasing disposable incomes, urbanization, and evolving attitudes toward eyewear contribute to this surge. Consequently, the demand for orthokeratology lens is projected to increase in India.

Latin America Orthokeratology Lens Trends

The Latin American orthokeratology lens market is fueled by the growing elderly demographic. Aging brings about heightened vulnerability to numerous chronic ailments, prompting the need for refractive surgery devices as a treatment option. This, coupled with the demand for medications, is propelling market growth in the region.

Saudi Arabia Orthokeratology Lens Market Trends

The orthokeratology lens market in Saudi Arabia is anticipated to expand in the forecast period. This is attributed to the government's encouragement of private sector involvement in healthcare, as outlined in the National Transformation Plan (NTP). Additionally, the projected rise in disposable income from economic expansion and urban development is expected to generate favorable growth prospects.

Key Orthokeratology Lens Company Insights

The competitive scenario in the market is highly competitive, with key players such as Bausch & Lomb Inc., CooperVision; and Johnson & Johnson Vision Care, Inc.. holding significant positions. The major companies are undertaking various organic as well as inorganic strategies such as new product development, collaborations, acquisitions, mergers, and regional expansion for serving the unmet needs of their customers.

Key Orthokeratology Lens Companies:

The following key companies have been profiled for this study on the orthokeratology lens market. 

  • Bausch & Lomb Inc.
  • Euclid Systems Corp.
  • CooperVision
  • Johnson & Johnson Vision Care, Inc.
  • Alpha Corporation (Menicon Group)
  • Brighten Optix, Co.
  • GP Specialists
  • TruForm Optics, Inc.
  • Art Optical Contact Lens, Inc.
  • MiracLens L.L.C.

Competitive Benchmarking

Category

Operating Strategies

Competitive Edge

Weakness

Established Players (Bausch & Lomb Inc.; Euclid Systems Corp.; CooperVision; Johnson & Johnson Vision Care, Inc.)

  • Established companies focus on expanding comprehensive orthokeratology portfolios comprising overnight Ortho-K lenses, customized rigid gas permeable (RGP) lenses, myopia management solutions, corneal topography technologies, lens fitting software, and vision correction platforms. They invest heavily in clinical research, practitioner training programs, myopia control studies, and partnerships with ophthalmologists, optometrists, and eye care institutions to strengthen product adoption and improve patient outcomes. These companies also emphasize global market expansion, regulatory approvals, and continuous lens design innovation.
  • Extensive global distribution networks, strong relationships with eye care professionals, robust clinical evidence, advanced manufacturing capabilities, and broad regulatory expertise. Large installed customer bases across ophthalmology and optometry practices support recurring demand. Comprehensive vision care portfolios and established brand recognition provide significant competitive advantages and facilitate practitioner loyalty.
  • Legacy product portfolios may face challenges adapting rapidly to emerging lens technologies, digital fitting solutions, and evolving myopia management protocols. Regulatory requirements, clinical validation demands, and increasing competition from alternative vision correction modalities can create operational complexities. Large organizational structures may also reduce agility compared with specialized orthokeratology manufacturers.

Emerging Players (Alpha Corporation (Menicon Group); Brighten Optix, Co.; GP Specialists; TruForm Optics, Inc.; Art Optical Contact Lens, Inc.; MiracLens L.L.C.)

  • Emerging companies prioritize innovation in customized orthokeratology lens designs, advanced corneal reshaping technologies, specialty contact lens solutions, digital fitting platforms, and next-generation myopia management products. They focus on addressing unmet needs in pediatric myopia control, astigmatism correction, personalized lens fitting, and enhanced patient comfort through targeted product development and niche market strategies.
  • Agile organizational structures enable faster innovation cycles, rapid product development, and responsiveness to practitioner requirements. Specialized expertise in orthokeratology, specialty contact lens manufacturing, customized lens design, and corneal reshaping technologies creates strong differentiation. Their ability to focus on niche vision correction applications allows targeted market positioning and innovation leadership within the orthokeratology segment.
  • Limited financial resources, narrower product portfolios, and smaller commercial infrastructures compared with multinational vision care companies. Restricted global distribution capabilities, lower brand recognition, and dependence on practitioner education and training may slow market expansion. Regulatory approvals, reimbursement limitations, and competition from established contact lens manufacturers can further challenge large-scale commercialization and adoption.

Get access to detailed company insights of key market participants. To know more request a free sample copy

Recent Developments

  • In April 2024,a study focused on comparing the effectiveness of various myopia control methods, including orthokeratology (ortho-k) and low-density red-light therapy, particularly in children up to age 13 with low to moderate myopia. The study highlighted ortho-k's efficacy in slowing axial elongation by 30% to 56%, establishing it as a leading optical treatment option. Other methods like myopia control soft contact lenses and spectacles also showed significant effects, emphasizing the importance of tailored approaches in managing myopia among children.

  • In September 2023, AccuLens introduced its NewVision SC orthokeratology lens, a corneo-scleral design recently cleared by the FDA. Crafted from Contamac Infinite material, it features a large diameter for enhanced comfort and wear-time flexibility. The lens incorporates four distinct zones for optimal myopia reduction, including customized base curves and alignment curves tailored to individual patients, ensuring effective treatment and comfort during daily wear.

  • In February 2021, Toray Industries, Inc. announced the establishment of a dedicated production line at its Shiga Plant for the Breath-O Correct orthokeratology lens, approved in Japan. Set to commence full-scale production in April 2021, this move aims to ensure stable supply and enhance competitiveness in the growing orthokeratology market.

Orthokeratology Lens Market Report Scope

Report Attribute

Details

Market size in 2025

USD 786.1 million

Estimated market size in 2026

USD 837.7 million

Projected market size by 2040

USD 1,256.5 million

Growth rate

CAGR of 6.0% from 2026 to 2040

Historical data

2021 - 2024

Forecast period

2026 - 2040

Quantitative units

Revenue in USD million/billion and CAGR from 2026 to 2040

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product type, indication, distribution channel, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; Norway; Denmark; Sweden; China; Japan; India; South Korea; Australia; Thailand; Brazil; Argentina; Saudi Arabia; South Africa; UAE; Kuwait;

Key companies profiled

Bausch & Lomb Inc.; Euclid Systems Corp.; CooperVision; Johnson & Johnson Vision Care, Inc.; Alpha Corporation (Menicon Group); Brighten Optix, Co.; GP Specialists; TruForm Optics, Inc.; Art Optical Contact Lens, Inc.; MiracLens L.L.C.

Customization scope

Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Orthokeratology Lens Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global orthokeratology lens market report on the basis of product, indication, distribution channel and region:

Global Orthokeratology Lens Market Report Segmentation

To learn more about this report, icon Download Free Sample Report

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

    • Overnight Ortho-K lenses

    • Day-time Ortho-K lenses

  • Indication Outlook (Revenue, USD Million, 2021 - 2033)

    • Myopia

    • Presbyopia

    • Hypermetropia

    • Astigmatism

  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

    • Hospitals

    • Optometry Clinics

    • Ophthalmology Clinics

    • Others

  • Region Outlook (Revenue, USD Million, 2021 - 2033)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Research Methodology

The orthokeratology lens market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each orthokeratology lens segment quantified using the revenue-capture definitions in the table below.

Segment Definition 

Segment - Product Type

Revenue capture definition

Overnight Ortho-K Lenses

Revenue generated from overnight orthokeratology lenses designed to be worn during sleep to temporarily reshape the cornea and provide clear daytime vision without the need for glasses or contact lenses. This segment includes customized rigid gas permeable (RGP) lenses, fitting services, replacement lenses, and associated orthokeratology treatment products.

Day-time Ortho-K Lenses

Revenue generated from orthokeratology lens solutions specifically designed for daytime wear or specialized corneal reshaping applications. The segment includes customized therapeutic and vision-correction lenses used for managing refractive errors while supporting patient-specific visual requirements.

Segment - Indication

Revenue capture definition

Myopia

Revenue generated from orthokeratology lenses prescribed for the correction and management of myopia (nearsightedness). This segment includes products and services aimed at improving visual acuity and slowing myopia progression, particularly among pediatric and adolescent patient populations.

Presbyopia

Revenue generated from orthokeratology lenses utilized for the correction and management of presbyopia, an age-related decline in near vision. The segment includes specialized lens designs intended to improve near and intermediate vision performance in presbyopic patients.

Hypermetropia

Revenue generated from orthokeratology lenses prescribed for the correction of hypermetropia (farsightedness). This segment includes customized lens solutions designed to reshape the cornea and improve focusing ability for near and distance vision.

Astigmatism

Revenue generated from orthokeratology lenses designed to correct corneal astigmatism by reshaping the corneal surface and reducing refractive irregularities. The segment includes toric and customized orthokeratology lens designs developed for astigmatic patients.

Segment - Distribution Channel

Revenue capture definition

Hospitals

Revenue generated from orthokeratology lens products, fitting procedures, diagnostic services, and follow-up care provided through hospitals and multi-specialty healthcare institutions offering ophthalmology and vision correction services.

Optometry Clinics

Revenue generated from orthokeratology lenses prescribed, fitted, and monitored through optometry clinics and vision care centers. This segment includes comprehensive eye examinations, corneal topography assessments, lens fitting services, replacement lenses, and ongoing patient management.

Ophthalmology Clinics

Revenue generated from orthokeratology lens treatments delivered through ophthalmology clinics and specialized eye care centers. The segment includes lens sales, diagnostic evaluations, clinical monitoring, and myopia management programs administered by ophthalmologists and eye care specialists.

Others

Revenue generated from orthokeratology lens products and services provided through other settings, including academic medical centers, specialty contact lens centers, ambulatory eye surgery centers, research institutions, military healthcare facilities, and community vision care programs.

Estimation Model 

Layer Name

Key Question

Process Steps

Data Sources

Scope

Definition

What is being sized?

Define orthokeratology lens categories including overnight Ortho-K lenses, daytime Ortho-K lenses.

Scope Product type, indication, distribution channel Segments

Set geographic boundaries (global / regional)

Align on base year & forecast horizon (2026–2033)

ASCRS, ESCP, WHO, FDA, CE Mark

Build the

Product Base

How large is total addressable market?

Assess the prevalence of myopia, hypermetropia, astigmatism, and presbyopia globally.

Evaluate pediatric and adult patient populations eligible for orthokeratology treatment.

Estimate orthokeratology lens utilization across key regions.

Forecast future patient volumes based on demographic and epidemiological trends.

National inpatient databases, hospital procurement databases, health ministry surgery registries

Estimate

Penetration

What portion of the market is active and utilizing advanced features?

Analyze adoption rates of orthokeratology compared with conventional contact lenses, spectacles, and refractive surgery.

Evaluate practitioner awareness and prescribing trends.

Examine regional variations in treatment adoption and accessibility.

Validate estimates through manufacturer sales data and practitioner interviews.

Primary interviews, company filings, trade surveys

Revenue

Conversion

How does volume become revenue?

Collect average selling prices of orthokeratology lenses, fitting services, replacement lenses, and follow-up care programs.

Segment by Revenue Streams

Assess recurring revenue from lens replacements and ongoing patient monitoring.

Cross-validate revenue estimates using company financial reports and distributor sales data.

Distributor pricing sheets, procurement data, import/export databases, expert interviews

Delivered Customizations

This report has been delivered with the following In-depth customizations

Client Request

Customization Delivered

Value Adds

Competitive Landscape Analysis

Conducted a comprehensive competitive landscape assessment for the orthokeratology lens market, covering overnight Ortho-K lenses, daytime Ortho-K lenses, customized RGP lens technologies, myopia management solutions, and specialty vision correction products. The study evaluated company positioning, product portfolio differentiation, lens design innovations, regulatory approvals, manufacturing capabilities, practitioner training programs, strategic partnerships, mergers and acquisitions, and geographic expansion initiatives. It also benchmarked established global manufacturers and emerging specialty lens providers to identify market share dynamics, innovation trends, pricing strategies, and competitive factors influencing adoption.

Enables stakeholders to understand the competitive dynamics of the orthokeratology lens market, benchmark technological capabilities, evaluate product differentiation strategies, identify partnership and acquisition opportunities, and strengthen market positioning in the rapidly growing myopia management sector.

Segment by Product Analysis

Conducted a detailed segment-level analysis across overnight Ortho-K lenses, daytime Ortho-K lenses, customized corneal reshaping lenses, and specialty myopia control products. The study assessed demand patterns, pricing trends, patient preferences, practitioner adoption rates, fitting requirements, replacement cycles, and technological advancements across key product categories. It further evaluated innovation trends such as advanced lens materials, digital fitting technologies, corneal mapping integration, and personalized lens design solutions influencing future market development.

Enables stakeholders to identify high-growth product categories, understand evolving practitioner and patient preferences, evaluate innovation opportunities, assess competitive intensity within individual segments, and align product development and commercialization strategies with emerging market needs.

Macroeconomic Analysis

Conducted an in-depth assessment of macroeconomic, demographic, and healthcare factors influencing the orthokeratology lens market, including increasing myopia prevalence, aging populations, healthcare expenditure growth, urbanization trends, rising screen exposure, access to eye care services, and awareness of preventive vision management. The study analyzed regulatory developments, reimbursement environments, supply chain dynamics, inflationary pressures, and technological advancements affecting market growth. Additionally, it evaluated the impact of pediatric eye care initiatives, digital device usage patterns, and expanding vision care infrastructure on treatment adoption.

Enables stakeholders to understand the key demographic, economic, healthcare, and regulatory factors driving or restraining market growth. The analysis supports strategic planning, investment prioritization, pricing optimization, market entry decisions, and long-term risk assessment across regional and global orthokeratology lens markets.

Frequently Asked Questions About This Report

About the Author(s)

Medical Devices Research Team

Healthcare · Medical Devices

This report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo